-
1
ON THE SELECTION OF DRUGS DOSAGE REGIMEN
Foilsithe / Cruthaithe 2015-09-01Ábhair: Faigh an téacs iomlán
Alt -
2
БЕЗОПАСНОСТЬ АНТИКОАГУЛЯНТНОЙ ТЕРАПИИ У БОЛЬНЫХ С ФИБРИЛЛЯЦИЕЙ ПРЕДСЕРДИЙ. КАК ОБЕСПЕЧИТЬ ПАЦИЕНТУ ОПТИМАЛЬНОЕ ЛЕЧЕНИЕ?...
Foilsithe / Cruthaithe 2014-12-01Ábhair: Faigh an téacs iomlán
Alt -
3
PRACTICAL APPLICATION OF DABIGATRAN ETEXILATE FOR STROKE PREVENTION IN PATIENTS WITH ATRIAL FIBRILLATION
Foilsithe / Cruthaithe 2015-09-01Ábhair: Faigh an téacs iomlán
Alt -
4
ANTICOAGULANT THERAPY IN EVERYDAY CLINICAL PRACTICE: DATA OF THE RETROSPECTIVE CROSS-SECTIONAL STUDY
Foilsithe / Cruthaithe 2015-09-01Ábhair: Faigh an téacs iomlán
Alt -
5
РИВАРОКСАБАН ПРИ ТРОМБОЗЕ ЛЕВОГО ПРЕДСЕРДИЯ У ПАЦИЕНТА С ФИБРИЛЛЯЦИЕЙ ПРЕДСЕРДИЙ ПРИ ПРОВЕДЕНИИ КАТЕТЕРНОЙ АБЛЯЦИИ...
Foilsithe / Cruthaithe 2014-12-01Ábhair: Faigh an téacs iomlán
Alt -
6
PRACTICAL ASPECTS OF APIXABAN USE IN CLINICAL PRACTICE: VIEW POINT OF CLINICAL PHARMACOLOGIST
Foilsithe / Cruthaithe 2015-09-01Ábhair: “…новые пероральные антикоагулянты…”
Faigh an téacs iomlán
Alt -
7
COST-EFFECTIVENESS OF APIXABAN AS COMPARED WITH WARFARIN AND ACETYLSALICYLIC ACID IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION IN THE RUSSIAN FEDERATION
Foilsithe / Cruthaithe 2015-09-01Ábhair: Faigh an téacs iomlán
Alt -
8
THE ASSESSMENT OF COMPLIANCE TO THE USE OF NEW ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION ACCORDING TO THE PROFILE REGISTER
Foilsithe / Cruthaithe 2015-09-01Ábhair: Faigh an téacs iomlán
Alt -
9
PHARMACOECONOMIC ASPECTS OF APIXABAN FOR PREVENTION OF THROMBOEMBOLIC EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION
Foilsithe / Cruthaithe 2015-09-01Ábhair: Faigh an téacs iomlán
Alt -
10
APPLICATIONS OF PHARMACOGENETIC TESTING FOR PERSONALIZATION OF THERAPY WITH ORAL ANTICOAGULANTS IN RUSSIA
Foilsithe / Cruthaithe 2015-09-01Ábhair: Faigh an téacs iomlán
Alt -
11
The main causes and current principles of prevention of cardioembolic stroke
Foilsithe / Cruthaithe 2015-12-01Ábhair: Faigh an téacs iomlán
Alt